Oryzon Genomics S.A. (0RDB)
Market Closed
16 Oct, 03:30 PM
€
2. 55
+0.03
+1.1905%
€
- Market Cap
- P/E Ratio
- Div Yield
1,960 Volume
- Eps
€ 2.52
Previous Close Want to track 0RDB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Oryzon Genomics S.A. (0RDB) Statistics
Valuation metrics
Market Cap -
Enterprise value 199.97M
Trailing P/E (ttm) -81.67
Forward P/E -
PEG ratio -1.4
Price/Sales (ttm) 57.45
Price/Book (mrq) 1.65
Enterprise Value/Revenue 53.9
Enterprise Value/EBITDA -29.18
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.01K
Average volume (90 days) 1.04K
Price summary
52-Week low 2.5
52-Week high 3.75
Beta -
50-Day moving average 2.74
200-Day moving average 2.88
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.52%
Operating margin -1.58%
Operational effectiveness
Return on assets -0.02%
Return on equity -0.02%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.05
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.03
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.19
Total debt (mrq) -
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 1.6%
Book value per share (mrq) 1.54
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
